Abstract
Evidence suggests that in some species (cats, rabbits, and possibly humans) α-adrenoceptors in the iris dilator muscle are “atypical” in that they cannot be readily classified by conventional criteria. This study was undertaken in an attempt to characterize the α-adrenoceptor subtype(s) mediating sympathetically elicited mydriasis in rats. Frequency-response pupillary dilator curves were generated by stimulation of the preganglionic cervical sympathetic nerve (1–32 Hz) in pentobarbital-anesthetized rats. Evoked responses were inhibited by systemic administration of nonselective α-adrenergic antagonists, phentolamine (0.3–10 mg/kg) and phenoxybenzamine (0.03–1 mg/kg). The selective α1-adrenergic antagonist, prazosin (0.01–1 mg/kg), also was effective, although α2-adrenergic antagonism with rauwolscine (0.1–1 mg/kg) was not. α1A-Adrenoceptor-selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1–1 mg/kg) and 5-methylurapidil (0.1–1 mg/kg), as well as the α1D-adrenoceptor-selective antagonist 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1–3 mg/kg), were used to determine the subtype(s) involved. Evoked mydriasis was significantly antagonized by both WB-4101 and 5-methylurapidil but not by BMY-7378. These results suggest that, unlike some other species, adrenoceptors in the rat iris dilator mediating neurogenic mydriasis are “typical” and, in addition, can be characterized as being primarily of the α1A-adrenoceptor subtype.
Footnotes
- Abbreviations:
- WB-4101
- 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane
- BMY-7378
- 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione
- Received October 4, 2001.
- Accepted October 30, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|